Highmount Capital’s Xylem XYL Stock Holding History

Highmount Capital’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$213K	Hold	5,737	–	–	0.05%	123
2015 Q1	$201K	Hold	5,737	–	–	0.05%	132
2014 Q4	$218K	Hold	5,737	–	–	0.05%	129
2014 Q3	$203K	Hold	5,737	–	–	0.05%	138
2014 Q2	$224K	Hold	5,737	–	–	0.05%	137
2014 Q1	$209K	Buy	+5,737	New	+$209K	0.05%	141

Other funds holding XYL

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Highmount Capital's XYL Position: Q2 2015 in Review

Highmount Capital held its Xylem (XYL) position steady in Q2 2015 at 5,737 shares worth $213K. The position accounts for 0.05% of the portfolio, ranked #123.

Highmount Capital first reported a position in XYL in Q1 2014 and has held it in 6 quarters since. The position peaked at $224K in Q2 2014. 438 funds tracked by Wall St. Rank hold XYL as of Q2 2015.

Highmount Capital held 5,737 shares of Xylem worth $213K as of Q2 2015.
Highmount Capital left its Xylem share count unchanged in Q2 2015.
Xylem made up 0.05% of Highmount Capital's portfolio in Q2 2015, its #123 holding.
Highmount Capital first reported a position in Xylem in Q1 2014 and has held it in 6 quarters since.
Highmount Capital's Xylem position peaked at $224K in Q2 2014.
438 funds tracked by Wall St. Rank held Xylem as of Q2 2015.

Based on Highmount Capital's 13F filing for Q2 2015, filed 14 Aug 2015.